Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Invested Capital (2022 - 2025)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Invested Capital of $82.04 million in Q4 2025, up 148.2% from $33.05 million a year earlier.

Analysis

Eupraxia Pharmaceuticals (EPRX) Invested Capital (2022 - 2025) Analysis & Trends

Starting with Q4 2022, Eupraxia Pharmaceuticals' Invested Capital history includes 6 quarters.

  • Annual Invested Capital has increased for three straight years, with a three-year compound annual growth rate of 122.7% (FY2022 to FY2025).
  • Across earlier years, Invested Capital came in at $33.05 million in FY2024 (+191.1%), $11.35 million in FY2023 (+52.8%) and $7.43 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 82.04 Mn
Dec 31, 2024 33.05 Mn
Jun 30, 2024 13.36 Mn
Mar 31, 2024 18.15 Mn
Dec 31, 2023 11.35 Mn
Dec 31, 2022 7.43 Mn
API Access

Eupraxia Pharmaceuticals Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=EPRX&period=max&api_key=YOUR_API_KEY